Top Stories
Sava is targeting CE approval for a sensor that could guide insulin dosing without routine fingerstick checks.
At the midpoint of its proposed offering, Iambic would raise $150 million.
The series D comes less than a month after the Italian company secured €17 million ($19.1 million) in funding.
The life sciences supplier plans to link AI, robotics and lab instruments at its Abcam unit to speed the design and testing of antibodies and other affinity reagents.
Zuckerberg's Biohub is combining new cell data with federal datasets to train AI models that can predict how cells respond to changes, helping researchers study disease and identify potential treatments.
Conference News
RadiusXR and Topcon Healthcare, Inc. unveil InspirePRO at AAO: the full measurement range expertly engineered into a lightweight wearable experience.Purpose-built medical-grade perimeter combines comp...
Posters explore whether HelioLiver™ Dx can flag hepatocellular carcinoma when ultrasound is negative, imaging is indeterminate, or a tumor is not yet visibleSAN ANTONIO, Oct. 9, 2026 /PRNewswire/ -- H...
OXFORD, United Kingdom, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Oxford Brain Diagnostics (OBD), a pioneer in quantitative brain biology, today announced new research demonstrating that its Cortical Disarray...
Four randomized, placebo-controlled trials (N=319) of SuperPatch haptic patches showed significant gains in sleep, pain, balance, and athletic performance.NARRAGANSETT, RI, UNITED STATES, October 9, 2...
BRANFORD, Conn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecul...
